US Broker Ratings

Biogen Inc. (BIIB) Stock Analysis: Exploring a 12.34% Potential Upside Amid Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB), a titan in the healthcare sector, particularly in the drug manufacturing industry, is capturing investor attention with a compelling potential upside of 12.34%. With a market..

Natera, Inc. (NTRA) Stock Analysis: Insights into a High-Growth Diagnostics Leader with a 20% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research sector, is drawing investor attention with its innovative molecular testing services and strong revenue growth. With a market..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Exploring a 39% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is capturing the attention of investors with its focus on groundbreaking therapies for metabolic dysfunction-associated steatohepatitis (MASH). With..

Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 19.89% Potential Upside

Investors eyeing opportunities in the healthcare sector may find Becton, Dickinson and Company (NYSE: BDX) a compelling option. With a robust market cap of $41.65 billion, BDX stands as a..

Agilent Technologies, Inc. (A) Stock Analysis: Healthcare Giant with 18.87% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, is renowned for its innovative solutions in the diagnostics and research industry. With a market capitalization of $38.25..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 23.79% Upside Potential with Strong Buy Ratings

IQVIA Holdings, Inc. (NYSE: IQV), a powerhouse in the diagnostics and research industry, stands as a key player in the healthcare sector. With a market capitalization of $30.62 billion, this..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and a 19% Potential Upside

Investors are paying close attention to Cardinal Health, Inc. (NYSE: CAH) as the company stands out in the healthcare sector with promising growth metrics and a favorable analyst outlook. With..

Novo Nordisk A/S (NVO) Stock Analysis: Tackling Diabetes and Obesity with a 9.07% Potential Upside

Novo Nordisk A/S (NYSE: NVO), a kingpin in the healthcare sector, remains a formidable player in the global drug manufacturing industry. Headquartered in Bagsvaerd, Denmark, the company is a juggernaut..

BioNTech SE (BNTX) Stock Analysis: Unpacking a 39% Potential Upside Amidst Challenging Metrics

BioNTech SE (NASDAQ: BNTX) stands as a prominent player in the biotechnology sector, with its roots deeply embedded in the healthcare landscape of Germany. Renowned for its groundbreaking mRNA vaccine,..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 29% Potential Upside Amid Robust Growth

The Ensign Group, Inc. (NASDAQ: ENSG) has positioned itself as a formidable player in the healthcare sector, specializing in medical care facilities. With a market capitalization of $9.95 billion, this..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a 54.74% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a key player in the biotechnology sector, is gaining traction among investors due to its innovative approach to treating rare diseases. Based in San Rafael,..

Illumina, Inc. (ILMN) Stock Analysis: Exploring Growth Potential Amidst Mixed Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector’s diagnostics and research industry, offers investors a compelling opportunity to delve into the burgeoning field of genetic and genomic analysis...

Boston Scientific Corporation (BSX) Stock Analysis: Strong Buy Ratings Signal Potential 61% Upside

Boston Scientific Corporation (NYSE: BSX) continues to capture investor attention with its robust market presence in the healthcare sector, specifically within the medical devices industry. As a major player based..

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring the 52.5% Upside Potential in Biotech

Investors looking to capitalize on the burgeoning field of biotechnology may find BeOne Medicines Ltd. (ONC) a compelling opportunity, particularly given the projected 52.5% upside potential based on current analyst..

Hologic, Inc. (HOLX) Stock Analysis: Steady Growth with a Focus on Women’s Health

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, commands a significant presence in the medical instruments and supplies industry. With a market capitalization of $16.97 billion, Hologic..

Gilead Sciences, Inc. (GILD): Investor Outlook Reveals 22% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a leading biopharmaceutical company headquartered in Foster City, California, presents an intriguing proposition for investors, particularly with its potential upside of 22.20%. With a market..

UnitedHealth Group (UNH) Stock Analysis: Evaluating Growth Potential Amidst a Robust $362 Billion Market Cap

As one of the cornerstones of the healthcare sector, UnitedHealth Group Incorporated (NYSE: UNH) stands out with its significant market capitalization of $362.78 billion. For investors seeking exposure to the..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a 36% Upside Potential in the Healthcare Sector

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable presence in the U.S. healthcare sector, commanding a significant market capitalization of $82.55 billion. As a leading provider in the medical..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 13.70% Potential Upside with a Strong Dividend Yield

Viatris Inc. (VTRS), a prominent player in the healthcare sector, is making headlines with its potential upside of 13.70% and a robust dividend yield of 3.02%. With a market capitalization..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 43.3% Potential Upside Despite Financial Challenges

Tempus AI, Inc. (NASDAQ: TEM) is capturing the attention of investors with its innovative approach to healthcare technology. Operating within the Health Information Services industry, this U.S.-based company offers a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds